Quantum BioPharma Statistics
Total Valuation
QNTM has a market cap or net worth of $55.63 million. The enterprise value is $54.67 million.
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025, after market close.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
QNTM has 3.82 million shares outstanding. The number of shares has increased by 254.05% in one year.
| Current Share Class | 3.82M |
| Shares Outstanding | 3.82M |
| Shares Change (YoY) | +254.05% |
| Shares Change (QoQ) | +22.06% |
| Owned by Insiders (%) | 10.63% |
| Owned by Institutions (%) | 24.94% |
| Float | 3.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 27.17 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 1.11.
| Current Ratio | 0.78 |
| Quick Ratio | 0.36 |
| Debt / Equity | 1.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -123.36 |
Financial Efficiency
Return on equity (ROE) is -456.81% and return on invested capital (ROIC) is -154.18%.
| Return on Equity (ROE) | -456.81% |
| Return on Assets (ROA) | -76.42% |
| Return on Invested Capital (ROIC) | -154.18% |
| Return on Capital Employed (ROCE) | -912.21% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.59M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +226.67% in the last 52 weeks. The beta is 1.40, so QNTM's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | +226.67% |
| 50-Day Moving Average | 18.50 |
| 200-Day Moving Average | 12.70 |
| Relative Strength Index (RSI) | 41.21 |
| Average Volume (20 Days) | 119,937 |
Short Selling Information
The latest short interest is 82,489, so 2.16% of the outstanding shares have been sold short.
| Short Interest | 82,489 |
| Short Previous Month | 61,807 |
| Short % of Shares Out | 2.16% |
| Short % of Float | 2.42% |
| Short Ratio (days to cover) | 0.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -18.67M |
| Pretax Income | -27.98M |
| Net Income | -27.02M |
| EBITDA | -18.17M |
| EBIT | -18.67M |
| Earnings Per Share (EPS) | -$12.31 |
Full Income StatementBalance Sheet
The company has $1.53 million in cash and $2.27 million in debt, giving a net cash position of -$736,778 or -$0.19 per share.
| Cash & Cash Equivalents | 1.53M |
| Total Debt | 2.27M |
| Net Cash | -736,778 |
| Net Cash Per Share | -$0.19 |
| Equity (Book Value) | 2.05M |
| Book Value Per Share | 1.09 |
| Working Capital | -2.91M |
Full Balance SheetCash Flow
| Operating Cash Flow | -10.51M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.51M |
| FCF Per Share | -$2.75 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
